JP2022530042A5 - - Google Patents
Info
- Publication number
- JP2022530042A5 JP2022530042A5 JP2021562971A JP2021562971A JP2022530042A5 JP 2022530042 A5 JP2022530042 A5 JP 2022530042A5 JP 2021562971 A JP2021562971 A JP 2021562971A JP 2021562971 A JP2021562971 A JP 2021562971A JP 2022530042 A5 JP2022530042 A5 JP 2022530042A5
- Authority
- JP
- Japan
- Prior art keywords
- sustained
- release formulation
- formulation according
- item
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025060888A JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837978P | 2019-04-24 | 2019-04-24 | |
| US62/837,978 | 2019-04-24 | ||
| US201962947183P | 2019-12-12 | 2019-12-12 | |
| US201962947188P | 2019-12-12 | 2019-12-12 | |
| US62/947,188 | 2019-12-12 | ||
| US62/947,183 | 2019-12-12 | ||
| PCT/US2020/029733 WO2020219822A1 (en) | 2019-04-24 | 2020-04-24 | Compositions and methods for modulating complement activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060888A Division JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530042A JP2022530042A (ja) | 2022-06-27 |
| JP2022530042A5 true JP2022530042A5 (cg-RX-API-DMAC10.html) | 2023-05-01 |
| JP7726791B2 JP7726791B2 (ja) | 2025-08-20 |
Family
ID=70977557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562971A Active JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
| JP2025060888A Pending JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060888A Pending JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122021025449B1 (pt) | 2014-06-12 | 2024-02-15 | Ra Pharmaceuticals, Inc | Composto, polipeptídeo e composição compreendendo o mesmo |
| SMT202100688T1 (it) | 2015-01-28 | 2022-01-10 | Ra Pharmaceuticals Inc | Modulatori di attività del complemento |
| KR20260070290A (ko) | 2015-12-16 | 2026-05-18 | 유씨비 홀딩스 인코포레이티드 | 보체 활성의 조절인자 |
| JP7301741B2 (ja) | 2016-12-07 | 2023-07-03 | ラ ファーマシューティカルズ インコーポレイテッド | 補体活性のモジュレータ |
| SG11202103972SA (en) * | 2018-10-22 | 2021-05-28 | Ra Pharmaceuticals Inc | Neurological disease treatment with zilucoplan |
| ES2973767T3 (es) | 2019-06-04 | 2024-06-24 | Ra Pharmaceuticals Inc | Tratamiento de enfermedades inflamatorias con inhibidores del complemento |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241139A (zh) * | 1996-12-20 | 2000-01-12 | 武田药品工业株式会社 | 生产缓释制剂的方法 |
| AU1705100A (en) | 1998-10-09 | 2000-05-01 | Musc Foundation For Research Development | Blocking factor b to treat complement-mediated immune disease |
| EP2266606B1 (en) | 2003-05-15 | 2014-09-10 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
| CN1289066C (zh) * | 2003-09-18 | 2006-12-13 | 中国人民解放军第二军医大学 | 胰高血糖素样肽-1缓释微球制剂及其用途 |
| US20060270590A1 (en) | 2005-03-29 | 2006-11-30 | Lockwood Samuel F | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| CN103505728A (zh) | 2005-05-26 | 2014-01-15 | 科罗拉多大学评议会法人机构 | 用于治疗外伤性脑损伤、脊髓损伤及相关病症的补体旁路抑制 |
| CN101374554A (zh) | 2005-09-27 | 2009-02-25 | 埃弗拉特生物聚合物有限公司 | 胶凝疏水性可注射聚合物组合物 |
| DK2500030T4 (en) | 2005-11-04 | 2018-10-29 | Genentech Inc | Use of complement pathway inhibitors for the treatment of eye diseases |
| CN101341254A (zh) * | 2005-12-24 | 2009-01-07 | 蒂加斯克乳制品研究中心 | 反-10,顺-12十八碳二烯酸的生产方法 |
| US20090028832A1 (en) * | 2006-08-10 | 2009-01-29 | Chung Leland F | Compositions and methods for targeted tumor therapy |
| LT3028716T (lt) | 2006-10-10 | 2020-12-10 | Regenesance B.V. | Komplemento slopinimas nervų regeneracijos pagerinimui |
| US7736860B2 (en) | 2006-11-09 | 2010-06-15 | Univeristy Of Massachusetts | Methods of identifying compounds for the treatment of sterile inflammation |
| US20100015139A1 (en) | 2008-07-10 | 2010-01-21 | Rekha Bansal | METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF |
| RU2009144142A (ru) | 2007-04-30 | 2011-06-10 | Алькон Рисерч, Лтд. (Us) | Лечение возрастной дегенерации желтого пятна с применением ингибиторов фактора d комплемента |
| AU2008262048B2 (en) | 2007-06-07 | 2013-09-26 | Genentech, Inc. | C3b antibodies and methods for the prevention and treatment of complement- associated disorders |
| WO2009014633A1 (en) | 2007-07-20 | 2009-01-29 | Trustees Of The University Of Pennsylvania | Method of treating acute respiratory distress syndrome |
| JP5473925B2 (ja) | 2007-10-27 | 2014-04-16 | コーデン ファーマ コロラド インコーポレイテッド | 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成 |
| US20110172126A1 (en) | 2008-09-03 | 2011-07-14 | Xenome Ltd | Libraries of peptide conjugates and methods for making them |
| US20100086596A1 (en) * | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for releasing an octreotide compound without an initial time lag |
| JP6223659B2 (ja) | 2008-11-10 | 2017-11-01 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 補体関連障害を処置するための方法および組成物 |
| EP3150635A3 (en) | 2009-10-16 | 2017-06-21 | Omeros Corporation | Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| WO2011106635A1 (en) | 2010-02-25 | 2011-09-01 | The Trustees Of The University Of Pennsylvania | Treatment of sepsis using complement inhibitors |
| WO2011137363A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| TW201241008A (en) * | 2010-10-01 | 2012-10-16 | Alexion Pharma Inc | Polypeptides that bind to human complement component C5 |
| DK2694108T3 (en) | 2011-04-08 | 2018-08-20 | Univ Leicester | METHODS OF TREATING DISEASES ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION |
| WO2012162215A1 (en) | 2011-05-20 | 2012-11-29 | The Trustees Of The University Of Pennsylvania | Promotion of fracture healing using complement inhibitors |
| WO2012174055A1 (en) | 2011-06-13 | 2012-12-20 | The Trustees Of The University Of Pennsylvania | Wound healing using complement inhibitors |
| US20130246083A1 (en) | 2012-03-16 | 2013-09-19 | Alexion Pharmaceuticals, Inc. | Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor |
| US9579360B2 (en) | 2012-06-20 | 2017-02-28 | The Trustees Of The University Of Pennsylvania | Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| WO2014004733A1 (en) | 2012-06-26 | 2014-01-03 | The Regents Of The University Of California | Composition for lupus nephritis and methods of making and using the same |
| WO2014078622A1 (en) | 2012-11-15 | 2014-05-22 | The Brigham And Women's Hospital, Inc. | Method and system for diagnosing and treating preeclampsia |
| US20140234275A1 (en) | 2013-02-15 | 2014-08-21 | Jason Williams | Method for treating als via the increased production of factor h |
| EP3089742A4 (en) * | 2013-12-31 | 2017-08-02 | Heron Therapeutics, Inc. | Polymer-based compositions for extended release of proteins |
| BR122021025449B1 (pt) | 2014-06-12 | 2024-02-15 | Ra Pharmaceuticals, Inc | Composto, polipeptídeo e composição compreendendo o mesmo |
| WO2016138520A1 (en) | 2015-02-27 | 2016-09-01 | The Johns Hopkins University | Assay to diagnose and treat disorders of the alternative pathway of complement activation |
| KR20260070290A (ko) * | 2015-12-16 | 2026-05-18 | 유씨비 홀딩스 인코포레이티드 | 보체 활성의 조절인자 |
| US20170333304A1 (en) * | 2016-05-20 | 2017-11-23 | Massachusetts Institute Of Technology | Hydrogel Particles, Compositions, and Methods |
| JP7301741B2 (ja) | 2016-12-07 | 2023-07-03 | ラ ファーマシューティカルズ インコーポレイテッド | 補体活性のモジュレータ |
| DK3411400T3 (da) * | 2017-04-03 | 2021-10-11 | Inflarx Gmbh | Behandling af inflammatoriske sygdomme med hæmmere af c5a-aktivitet |
-
2020
- 2020-04-24 CN CN202080030772.3A patent/CN113710230A/zh active Pending
- 2020-04-24 SG SG11202109837S patent/SG11202109837SA/en unknown
- 2020-04-24 EP EP20730497.3A patent/EP3958842B1/en active Active
- 2020-04-24 US US17/605,495 patent/US20220211799A1/en active Pending
- 2020-04-24 BR BR112021017820A patent/BR112021017820A2/pt not_active Application Discontinuation
- 2020-04-24 AU AU2020261059A patent/AU2020261059A1/en not_active Abandoned
- 2020-04-24 WO PCT/US2020/029733 patent/WO2020219822A1/en not_active Ceased
- 2020-04-24 CA CA3137895A patent/CA3137895A1/en active Pending
- 2020-04-24 KR KR1020217034548A patent/KR20220004039A/ko not_active Withdrawn
- 2020-04-24 JP JP2021562971A patent/JP7726791B2/ja active Active
- 2020-04-24 TW TW109113822A patent/TW202106290A/zh unknown
- 2020-04-24 MX MX2021013010A patent/MX2021013010A/es unknown
-
2021
- 2021-10-07 IL IL287079A patent/IL287079A/en unknown
-
2025
- 2025-04-02 JP JP2025060888A patent/JP2025118607A/ja active Pending
- 2025-10-22 US US19/366,293 patent/US20260216276A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025118607A5 (cg-RX-API-DMAC10.html) | ||
| TWI241911B (en) | Sustained release ranolazine formulations | |
| Ungaro et al. | Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs | |
| US20080057129A1 (en) | Drug microparticles | |
| CN113018277B (zh) | 注射用缓释制剂及其制备方法 | |
| MX2008016254A (es) | Uso de agonistas del receptor de adenosina a2a en el tratamiento de isquemia. | |
| CN110339166B (zh) | 一种利拉鲁肽多囊脂质体及其制备方法和应用 | |
| TW200812642A (en) | Compositions and methods for treating conditions of the nail unit | |
| JP2022009026A (ja) | 低ナトリウムポロキサマー188製剤および使用方法 | |
| WO2014069401A1 (ja) | 肺疾患特異的治療剤 | |
| JP2024545887A (ja) | 安定した受容体アゴニストの医薬組成物、製造方法及びその応用 | |
| EP3307236A1 (en) | Process for the preparation of porous microparticles | |
| FR2582511A1 (fr) | Systeme d'application endonasal | |
| JP3852621B2 (ja) | 血管内皮細胞機能改善剤 | |
| JP2022062153A (ja) | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 | |
| JP2022527276A5 (cg-RX-API-DMAC10.html) | ||
| WO2000050015A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine | |
| CN117205319B (zh) | Hc030031在制备预防或治疗百草枯中毒引起的肺损伤的药物中的应用 | |
| JP7854206B2 (ja) | 肺線維症の予防または治療用の薬学製剤 | |
| AU2003272857B2 (en) | A controlled release system containing temozolomide | |
| CN108472333A (zh) | 组合 | |
| JP7518149B2 (ja) | 高濃度インスリン製剤 | |
| WO2015197535A1 (en) | Modified release pharmaceutical compositions of sofosbuvir and ribavirin | |
| WO2022166778A1 (zh) | 一种衣壳蛋白抑制剂的药物组合物及其制备方法 | |
| CN115569115A (zh) | 一种同时包载全氟化碳和二甲双胍的脂质纳米制剂及其制备方法与应用 |